The Food and Drug Administration last week alerted health care providers and laboratory personnel to a cybersecurity vulnerability affecting the Universal Copy Service software in certain Illumina medical devices used to sequence DNA for clinical diagnostic use or research. According to the FDA, an unauthorized user could exploit the vulnerability to take control of the device remotely; alter settings, software or data on the device or customer’s network; or affect or breach genomic data results. Customers should review the company’s April 5 notice, immediately install the software patch and contact the company at techsupport@illumina.com if they suspect their device has been compromised. For more on the vulnerability, see the Cybersecurity & Infrastructure Security Agency's April 27 advisory.

Related News Articles

Headline
Microsoft July 19 issued an alert about active attacks from vulnerabilities targeting SharePoint servers used within organizations. The incidents have not…
Headline
In his latest AHA Cyber and Risk Intel blog, Scott Gee, AHA deputy national advisor for cybersecurity and risk, explains how hospitals can prepare for and…
AHA Cyber Intel
In today’s heightened threat environment, driven by domestic and geopolitical issues, it is more critical than ever for hospitals to prepare for and mitigate…
Headline
In a statement submitted to the Senate Health, Education, Labor and Pensions Committee for a hearing today on health care cybersecurity and patient privacy,…
Headline
Cyberattacks on hospitals are urgent threats to patient safety, care delivery and public trust. In this conversation, Ajay Gupta, board chair of Trinity Health…
Headline
The Food and Drug Administration yesterday released a safety notice announcing a software patch is available to address cybersecurity vulnerabilities in…